CRSP

CRISPR THERAPEUTICS AG

Healthcare | Mid Cap

-$1.02

EPS Forecast

$7.7

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2026-12-31
DNLIDenali Therapeutics IncNVAXNovavax IncNBIXNeurocrine Biosciences IncRGENRepligen CorpMRNAModerna IncHALOHalozyme Therapeutics IncIOVAIovance Biotherapeutics IncREPLReplimune Group Inc